Related Experiment Video
Updated: Jun 29, 2025

MRI-guided Focused Ultrasound Thalamotomy for Patients with Medically-refractory Essential Tremor
Published on: December 13, 2017
[Essential Tremor: Update of Therapeutic Strategies]
Alexandre Gironell1, Juan Marín-Lahoz2, Santiago Póveda1
1Unidad de Trastornos del Movimiento, Servicio de Neurología, Hospital de la Santa Creu i Sant Pau, Barcelona, España.
Current essential tremor (TE) treatments show limited pharmacological success. Surgical options like focused ultrasound thalamotomy offer effective solutions for severe cases, with ongoing research for better therapies.
Area of Science:
- Neurology
- Neurosurgery
Background:
- Essential tremor (TE) treatment has seen advancements, particularly in surgical interventions, while pharmacological approaches remain less effective.
- Current non-pharmacological and non-surgical strategies include general advice, occupational therapy, speech therapy, and psychotherapy.
Purpose of the Study:
- To review currently available treatments for essential tremor (TE).
- To assess the efficacy and limitations of pharmacological and surgical interventions for TE.
Main Methods:
- Literature review of essential tremor treatments.
- Analysis of non-pharmacological, pharmacological, and surgical therapeutic options.
Main Results:
- Pharmacological treatments for TE show limited success, with 30-60% of patients responding positively and 40-60% experiencing anti-tremor effectiveness.
- First-line drugs include propranolol and primidone.
- High-intensity focused ultrasound thalamotomy is the preferred surgical option for severe essential tremor.
Conclusions:
- Further research into TE pathophysiology is crucial.
- Development of targeted TE drugs and improved invasive surgical techniques is needed.
- Surgical interventions, particularly focused ultrasound thalamotomy, represent a significant advancement for severe essential tremor cases.
More Related Videos
07:14A Novel Approach to Assess Motor Outcome of Deep Brain Stimulation Effects in the Hemiparkinsonian Rat: Staircase and Cylinder Test
Published on: May 31, 2016
04:29Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression
Published on: January 7, 2019
Related Concept Videos
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Drug Therapy
Antianxiety Medications
Alzheimer's Disease: Treatment
Electroconvulsive Therapy
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Centrally Acting Muscle Relaxants: Therapeutic Uses
Centrally acting drugs are classified into spasmolytic and antispasmodic drugs. Spasmolytic drugs such as baclofen, diazepam, and tizanidine inhibit spinal motor neurons and decrease muscle tone. Spasmolytic drugs are administered for severe and chronic spasms due to multiple sclerosis, cerebral palsy, stroke, and spinal cord and muscle injuries. However,...